Events Archive

Packages of Interventions for Adolescent Girls and Young Women: What is the right mix?

Recording / Slides Please join the South-to-South Learning Network for a webinar on reaching adolescent girls and young women with HIV prevention services. The objectives of this webinar are: To share global guidance on packages of HIV prevention interventions for adolescent girls and young women (AGYW) To provide a comprehensive review of evidence-based strategies and…

Building a Brand for PrEP: Positioning PrEP in the hearts and minds of young people

Recording / Slides With choice of PrEP products on the horizon – including oral PrEP, the PrEP ring, and injectable cabotegravir for PrEP (CAB PrEP) – PrEP marketing and demand generation must evolve with the availability of new PrEP products. Young people, in particular, need PrEP demand generation campaigns tailored to their needs and aspirations.…

New Data, New Opportunities: The expanding evidence base for the PrEP ring

Three MTN studies – REACH, DELIVER, and B-PROTECTED – recently published critical new data on PrEP ring use among adolescent girls and young women (AGYW), pregnant individuals, and breastfeeding individuals in Africa. All studies offer compelling evidence that the ring is safe for use among these populations. Moreover, the REACH study is the first to…

Spotlight on New Tools and Data: From R&D to Access

Slides / Recording Between the recent accelerated growth in global PrEP initiations, and the introduction of new PrEP products like cabotegravir and the dapivirine vaginal ring, the field of PrEP data has never been more exciting or more complex. Staying on top of the latest advances is key for advocates, researchers, funders, and others working…

PrEP Resources Showcase

Calling for collaboration: This dynamic, workshop-style showcase was the the first in a series that will feature multi-media presentations to take you through key resources including a toolkit to ensure programs related to sexual and reproductive health (SRH) and HIV prevention are well designed to reach and support adolescent girls and young women (AGYW); and…

HPTN 096: Building Equity Through Advocacy – An Integrated, Status-Neutral Approach for Ending the Epidemic Among Black Gay Men in the South

Recording / Slides / Resources Please join The Choice Agenda and partners on November 15 for a fascinating discussion about a novel, much-needed HIV prevention research study – HPTN 096. Currently in the field, the study addresses social, structural, institutional, and behavioral barriers to HIV prevention and care. Visit the study website here. Speakers will…

Pioneering Self-Care Solutions to Drive Access to HIV Prevention and Family Planning

This online session, part of the 2023 Self-Care Learning and Discovery Series, will amplify lessons from five self-care interventions in family planning and HIV prevention — with case studies on DMPA-SC, the Caya Diaphragm, the Dual Prevention Pill, HIV self-testing, and Triggerise, an mHealth platform – to highlight successful self-care strategies applicable across settings and…

Beyond Engagement: Bringing the Power of Young People to PrEP Research and Programs

Slides / Recording / Notes Expanding access to and uptake of PrEP products among young people, especially adolescent girls and young women, will be key to ending the HIV epidemic. But how do we ensure HIV prevention efforts resonate with and are effective for young millennials and Gen Z? What does meaningful youth engagement in…

How do People Who Use/Inject Drugs Intersect with PrEP Research and Service Delivery?

Recording / Slides / Resources On Wednesday, September 6, please make plans to join The Choice Agenda (TCA), the International Network of People Who Use Drugs (INPUD) and our wonderful expert speakers to discuss the health and wellness priorities of people who use/inject drugs, and how these communities (“key populations”) intersect across PrEP research, development,…

PrEP That Booty: The latest on rectal microbicide research for the back door

Thursday, June 29 at 9:00 AM–10:30AM ET Most of what we hear about regarding the HIV prevention pipeline is about long-acting, longer-acting, and even longer-acting products that deliver drug throughout the body and require a trained clinician to deliver. However, these attributes are not desirable to many folks, and communities want a range of choices.…